Login to Your Account

IntraBiotics Raises $39M To Advance Iseganan In Clinic

By Karen Pihl-Carey

Thursday, May 6, 2004
Enabling IntraBiotics Pharmaceuticals Inc. to ramp up its clinical programs for iseganan, the company raised $39 million gross in a public stock offering Wednesday. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription